This 160-page report, “Global Medical Simulation Market 2020-2026 by Product & Service (Model-based Simulation, Web-based Simulation, Simulation Training Services), Fidelity (High, Medium, Low), End User, and Region: COVID-19 Impact and Growth Opportunity,” is highlighted by 88 tables and 78 figures and is based on an in-depth analysis of the entire global medical simulation market and all of its sub-segments. Premium primary and secondary information sources are used to create in-depth research and evaluation, with input coming from business specialists working throughout the value chain.
The growing incidence of chronic diseases and population, growing patient safety concerns, the increased demand for minimally invasive surgery (MIS), and technological advancement will all contribute to the global medical simulation market reaching $4,375.0 million by 2026, growing by 14.46% annually over 2020-2026.
The study uses 2019 as the foundation year for forecasts from 2020 to 2026 and is based on research from 2016 to 2019. (Please note that the report will be updated before to delivery to ensure that the forecast includes at least 5 years beyond the base year and the most recent historical year serves as the base year.)
Request Research Sample with Latest Industry Insights: https://altusmarketresearch.com/reports/sample/3462
The following elements are identified and examined in-depth qualitative analyses:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
By taking COVID-19 into consideration, the trend and prognosis for the global market are predicted with an upbeat, fair-minded, and cautious viewpoint. The worldwide medical simulation market is quantified from the viewpoints of Product & Service, Fidelity, End User, and Region using the balanced (most likely) forecast.
The worldwide market is divided into the following sub-markets based on Product & Service, with annual revenue ($ mn) for 2016–2026 mentioned in each area.
Model-based Simulation
• Patient Simulation (further segmented into Manikin-based Simulation, Task Trainer Simulation, Hybrid Manikin-based simulation, Standardized Patient Simulation)
• Surgical Simulation (further split into Cardiovascular Simulators, Laparoscopic Surgical Simulators, Gynecology Simulators, Arthroscopic Surgical Simulators, Orthopedic Simulators, Endovascular Simulators, Spine Simulators, Other Surgical Simulations)
• Ultrasound Simulation (further segmented into Cardiology, Anesthesia, Intensive Care Unit, Emergency Medicine, OB/GYN, Radiology, Other Ultrasound Simulations)
Web-based Simulation
• Virtual Tutors
• Performance Recording Software
• Simulation Software
• Learning Management Software
Simulation Training Services
• Vendor-based Training
• Custom Consulting Services
• Educational Societies
Based on Fidelity, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
• Low-fidelity
• Medium-fidelity
• High-fidelity
Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
• Academic Institutions & Research Centers
• Hospitals & Clinics
• Military Organizations
• Other End Users
Along with the above national/local markets, the following geographic areas are thoroughly investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
In Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• America, North (U.S., Canada, and Mexico)
Latin America (Brazil, Columbia, Argentina, Rest of South America)
• MEA (Saudi Arabia, UAE, South Africa)
Detailed analysis and statistics for yearly revenue ($ mn) for each area and important nation are accessible for the years 2016 through 2026. All regional markets are broken down by country, and major national markets are divided throughout the projection years based on Product & Service, Fidelity, and End User.
The study also analyses the present competition landscape, the anticipated trend, and it provides profiles of major suppliers, including both established market leaders and significant up-and-coming companies.
Through AMR’s Risk Assessment System, possible risks related to investments in the worldwide medical simulation industry are evaluated quantitatively and qualitatively. Critical Success Factors (CSFs) are developed based on the risk analysis and assessment as a guide to assist investors and shareholders in identifying new possibilities, managing and minimising risks, developing suitable business models, and making informed strategies and choices.
Key Players (this may not be a complete list and extra companies can be added upon request):
3D Systems Corporation
Canadian Aviation Electronics, Ltd. (CAE)
Gaumard Scientific Company
Intelligent Ultrasound Group Plc (Formerly Medaphor Group Plc)
Kyoto Kagaku Co., Ltd.
Laerdal Medical AS
Limbs & Things Ltd.
Mentice AB
Simulab Corporation
Simulaids, Inc.
Surgical Science Sweden AB
Virtamed AG
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
